Skip to main content
Premium Trial:

Request an Annual Quote

The Forks in the Road

Computer scientists have three choices in a career, blogs Mark Chu-Carroll at Good Math, Bad Math. They can do academic research, industrial research, or industrial development. Chu-Carroll says these paths differ on five points: freedom, funding, time and scale, results, and impact. Funding, he points out, is "a direct tradeoff with freedom: the more freedom you have, the more you're stuck working to get resources; the more constrained you are, the more secure your funding situation is." For time and scale, Chu-Carroll notes that academics can take on longer-term, ambitious ideas but industry people often can only map put a project for a year or so. Then, the results coming out of the work are different: in academia, you get publications while in industry, you produce a prototype or a product. Impact, though, is what Chu-Carroll says is important to him. "My work actually matters to people. The importance of that can't be overstated," he says.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.